These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 946587)
21. Particle size of dexamethasone incorporated in ointment and its behaviour during penetration in the stratum corneum of living skin. Kleine-Natrop HE Dermatologica; 1976; 152 Suppl 1():101-6. PubMed ID: 955231 [TBL] [Abstract][Full Text] [Related]
22. Study of tolnaftate release from fatty acids containing ointment and penetration into human skin ex vivo. Kezutyte T; Drevinskas T; Maruska A; Rimdeika R; Briedis V Acta Pol Pharm; 2011; 68(6):965-73. PubMed ID: 22125963 [TBL] [Abstract][Full Text] [Related]
23. Absorption of indomethacin and its calcium salt through rat skin: effect of penetration enhancers and relationship between in vivo and in vitro penetration. Ogiso T; Ito Y; Iwaki M; Atago H J Pharmacobiodyn; 1986 Jun; 9(6):517-25. PubMed ID: 3761139 [TBL] [Abstract][Full Text] [Related]
24. Increased norfloxacin skin permeability for fatty alcohol propylene glycol (FAPG) ointment by optimized process of preparation: behavior of stearic acid in stratum corneum lipids. Lin HH; Hsu LR; Wu PC; Tsai YH Biol Pharm Bull; 1995 Nov; 18(11):1560-5. PubMed ID: 8593480 [TBL] [Abstract][Full Text] [Related]
25. Psoralens percutaneous permeation across the human whole skin and the epidermis in respect to their polarity (in vitro study). Saïd A; Makki S; Muret P; Humbert P; Millet J J Dermatol Sci; 1997 Feb; 14(2):136-44. PubMed ID: 9039977 [TBL] [Abstract][Full Text] [Related]
26. In vitro skin penetration of griseofulvin in rat and human skin from an ointment dosage form. Ritschel WA; Hussain AS Arzneimittelforschung; 1988 Nov; 38(11):1630-2. PubMed ID: 3214448 [TBL] [Abstract][Full Text] [Related]
27. [Experimental results of the optimization of external prednisolone therapy]. Wohlrab W; Taube KM; Wozniak KD Pharmazie; 1987 Jun; 42(6):400-2. PubMed ID: 3671461 [TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo study of 5-methoxypsoralen skin concentration after topical application. Colombo G; Zucchi A; Allegra F; Colombo P; Zani F; Santi P Skin Pharmacol Appl Skin Physiol; 2003; 16(2):130-6. PubMed ID: 12637789 [TBL] [Abstract][Full Text] [Related]
29. Nanoliposomes@Transcutol for Sinico C; Maria Fadda A; Valenti D; Pireddu R; Corrias F; Schlich M; Pitzanti G; Lai F J Nanosci Nanotechnol; 2021 May; 21(5):2901-2906. PubMed ID: 33653456 [TBL] [Abstract][Full Text] [Related]
30. [Penetration kinetics of fluocortolone from a new base for ointment and creme (author's transl)]. Flasch H; Hofferber E Arzneimittelforschung; 1980; 30(4):652-6. PubMed ID: 7190408 [TBL] [Abstract][Full Text] [Related]
31. The "bubble point" for validation of drug release or simulated absorption tests for ointments. Realdon N; Tagliaboschi A; Perin F; Ragazzi E Pharmazie; 2005 Dec; 60(12):910-6. PubMed ID: 16398267 [TBL] [Abstract][Full Text] [Related]
32. Effect of polyamidoamine dendrimer G3 and G4 on skin permeation of 8-methoxypsoralene--in vivo study. Borowska K; Wołowiec S; Rubaj A; Głowniak K; Sieniawska E; Radej S Int J Pharm; 2012 Apr; 426(1-2):280-283. PubMed ID: 22310461 [TBL] [Abstract][Full Text] [Related]
33. Effect of ointment bases on topical and transdermal delivery of salicylic acid in rats: evaluation by skin microdialysis. Murakami T; Yoshioka M; Okamoto I; Yumoto R; Higashi Y; Okahara K; Yata N J Pharm Pharmacol; 1998 Jan; 50(1):55-61. PubMed ID: 9504435 [TBL] [Abstract][Full Text] [Related]
34. Effects of various vehicles on the penetration of flufenamic acid into human skin. Wagner H; Kostka KH; Adelhardt W; Schaefer UF Eur J Pharm Biopharm; 2004 Jul; 58(1):121-9. PubMed ID: 15207545 [TBL] [Abstract][Full Text] [Related]
35. In vitro skin absorption and drug release - a comparison of six commercial prednicarbate preparations for topical use. Lombardi Borgia S; Schlupp P; Mehnert W; Schäfer-Korting M Eur J Pharm Biopharm; 2008 Feb; 68(2):380-9. PubMed ID: 17574402 [TBL] [Abstract][Full Text] [Related]
36. Plasma and skin concentration of 5-methoxypsoralen in psoriatic patients after oral administration. Zucchi A; Raho E; Marconi B; Nicoli S; Santini M; Allegra F; Colombo P; Bettini R; Santi P J Invest Dermatol; 2001 Aug; 117(2):379-82. PubMed ID: 11511320 [TBL] [Abstract][Full Text] [Related]
37. [Penetration kinetics of potential virustatics into the human skin]. Wohlrab W; Helbig B; Klöcking R; Sprössig M Pharmazie; 1984 Aug; 39(8):562-4. PubMed ID: 6504982 [TBL] [Abstract][Full Text] [Related]
38. [Pharmacokinetics and biotransformation of the antimycotic drug ciclopiroxolamine in animals and man after topical and systemic administration]. Kellner HM; Arnold C; Christ OE; Eckert HG; Herok J; Hornke I; Rupp W Arzneimittelforschung; 1981; 31(8A):1337-53. PubMed ID: 7197541 [TBL] [Abstract][Full Text] [Related]
39. Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: Formulation development, in vitro and in vivo evaluation of skin deposition. Kassem AA; Abd El-Alim SH; Asfour MH Int J Pharm; 2017 Jan; 517(1-2):256-268. PubMed ID: 27956194 [TBL] [Abstract][Full Text] [Related]
40. A HCl/alcohol formulation increased 5-aminolevulinic acid skin distribution using an ex vivo full thickness porcine skin model. Maisch T; Worlicek C; Babilas P; Landthaler M; Szeimies RM Exp Dermatol; 2008 Oct; 17(10):813-20. PubMed ID: 18380780 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]